Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris: Results from the APSIS study
- 31 January 2000
- journal article
- clinical trial
- Published by Elsevier BV in Atherosclerosis
- Vol. 148 (1), 179-188
- https://doi.org/10.1016/s0021-9150(99)00240-3
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Platelet aggregability in vivo is attenuated byverapamil but not bymetoprolol in patients with stable angina pectorisThe American Journal of Cardiology, 1995
- Intraindividual variability of fibrinogen levels and cardiovascular risk profile.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart StudyThe Lancet, 1993
- Influence of platelet size on outcome after myocardial infarctionThe Lancet, 1991
- Platelet Hyperreactivity and Prognosis in Survivors of Myocardial InfarctionNew England Journal of Medicine, 1990
- A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factorsAmerican Heart Journal, 1988
- Fibrinogen and risk of cardiovascular disease. The Framingham StudyPublished by American Medical Association (AMA) ,1987
- Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic DeathNew England Journal of Medicine, 1984
- Essential hypertension. The behaviour of the haemorheological determinants and their trends during beta-blocker treatment.Japanese Heart Journal, 1983
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980